To be a leading endocrine focused bio-pharmaceutical company by
Achieving this vision will benefit our stakeholders including patients and employees
We will invest in our antibody discovery capabilities to generate differentiated, best-in-class product candidates. We will convert these products candidates into high value clinical assets through creative development strategies. We will seek to establish a US commercial presence focused on specialized physicians who treat endocrine diseases with a targeted sales force, complemented by strategic partnerships.